Nature's Pharmacy for Diabetes: What Sixteen Medicinal Plants Tell Us About Tackling High Blood Sugar
A new review article published in The Open Biochemistry Journal by Dr. Maria Trapali of the Laboratory of Chemistry, Biochemistry and Cosmetic Science, Department of Biomedical Medicine, University of West Attica, Egaleo, Attiki, Greece — together with co‑authors Sara Ouari, Nadia Benzidane, Lekhmici Arrar, and Noureddine Bribi
The scale of the problem is immense: in 2024, the International Diabetes Federation estimated that approximately 589 million adults worldwide were living with diabetes, with more than 80 percent of cases concentrated in low‑ and middle‑income countries where access to standard treatment is limited. Conventional drugs carry side effects, keeping interest in plant‑based alternatives strong. This review set out to move beyond traditional claims and evaluate what the scientific literature reveals — at the molecular level — about how these plants exert anti‑diabetic effects.
How the Review Was Conducted — and What the Plants Do
The researchers searched three major academic databases — Scopus, ScienceDirect, and Google Scholar — covering studies published between 2000 and 2025. From more than 1,200 records, they applied strict selection criteria to arrive at 54 studies covering 16 medicinal plants with documented molecular evidence of anti‑diabetic activity.
These included well‑known species such as Gymnema sylvestre (Gurmar), white mulberry ( Morus alba ), pomegranate ( Punica granatum ), and red ginseng ( Panax ginseng ), alongside lesser‑known ones such as Wisteria sinensis , Dittrichia viscosa , and Phellinus igniarius .
Across this diverse group, the active compounds — chiefly flavonoids, polyphenols, alkaloids, and saponins — were found to act through consistent pathways. They slow carbohydrate digestion in the gut by blocking enzymes (α‑amylase and α‑glucosidase), enhance cellular glucose uptake via insulin‑signalling proteins, and protect the pancreas, liver, and kidneys from oxidative stress.
Among the most compelling compounds identified were quercetin, kaempferol, berberine, and gymnemic acid, which showed clear and reproducible effects across multiple studies. Four plants — Gymnema sylvestre , Morus alba , Punica granatum , and red ginseng — earned the strongest overall rating based on the volume and quality of evidence.
Why the Findings Matter — and What Still Needs to Be Done
The review carefully distinguishes between laboratory findings and what can be confirmed as safe and effective for human use. Most studies were conducted in cell cultures or animal models, and clinical trials in humans remain scarce.
Critical factors — including absorption, metabolism, consistency of plant extract composition across batches, and safe dosage ranges — are still inadequately studied. The authors call for more rigorous, standardised research, particularly well‑designed human trials, to bridge the gap between promising laboratory evidence and reliable medical practice.
The review argues that the convergence of evidence around shared biological pathways makes plant‑based compounds a legitimate area for pharmaceutical development. Addressing current knowledge gaps could eventually lead to effective, plant‑derived treatments that complement or, for some patients, replace conventional diabetes medication.
The article "Molecular Anti-diabetic Potential of Medicinal Plants: A Review" was published in The Open Biochemistry Journal, Volume 20, 2026.
Read the published article here: https://bit.ly/4w7s8na
JOURNAL
The Open Biochemistry Journal
DOI: 10.2174/011874091X465477260531222257
If you want to publish your article please visit : https://bit.ly/4de0DRi
The Open Biochemistry Journal
10.2174/011874091X465477260531222257
Molecular Anti-diabetic Potential of Medicinal Plants: A Review
3-Jun-2026